Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported
Marianno Franzini, Luigi Valdenassi, Giovanni Ricevuti, Salvatore Chirumbolo, Markus Depfenhart, Dario Bertossi, Umberto Tirelli
Topics & Concepts
ARDSMedicineOzone therapyOxygen therapyCoronavirus disease 2019 (COVID-19)OxygenationRespiratory systemVentilation (architecture)Mechanical ventilationFraction of inspired oxygenIntensive care medicineIntensive careAnesthesiaInternal medicineLungDiseaseInfectious disease (medical specialty)PathologyEngineeringMechanical engineeringAlternative medicineMedical and Biological Ozone ResearchLong-Term Effects of COVID-19Hydrogen's biological and therapeutic effects